Stock VNDA VANDA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Real-time Estimate Cboe BZX
Other stock markets
 11:24:08 2024-04-16 am EDT 		5-day change 1st Jan Change
4.045 USD -0.37% Intraday chart for Vanda Pharmaceuticals Inc. -7.00% -3.91%
Apr. 03 Top Midday Gainers MT
Apr. 03 Vanda Pharmaceuticals Shares Soar After FDA Approval for Bipolar I Disorder Therapy MT

Summary

Search
See the results
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Top Midday Gainers
MT
Vanda Pharmaceuticals Shares Soar After FDA Approval for Bipolar I Disorder Therapy
MT
VANDA Pharmaceuticals States A Fifth Amendment Claim Against The Government For Taking A Trade Secret
AQ
Powell Speech Eyed, Intel Weighs on Sentiment as US Equity Futures Waver Premarket
MT
Sector Update: Health Care Stocks Flat Pre-Bell Wednesday
MT
Sector Update: Health Care
MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday as Bets Lean Towards Smaller Rate Cuts
MT
Top Premarket Gainers
MT
North American Morning Briefing : Powell Awaited as Inflation Fears Continue to Damp Mood
DJ
Vanda Pharmaceuticals Secures FDA Approval for Bipolar I Disorder Therapy; Shares Rise Pre-Bell
MT
US FDA approves Vanda's drug for treatment of bipolar disorder
RE
US FDA approves Vanda's drug for bipolar disorder
RE
Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
PR
Vanda Pharmaceuticals' Fanapt (Iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder
CI
Stocks to Watch : Intel, Vanda Pharmaceuticals, OneMedNet
DJ
Vanda Pharmaceuticals Shares Jump 17% After FDA Approved Fanapt for Bipolar I Disorder
DJ
Vanda Pharmaceuticals' Fanapt Gets FDA Approval for Bipolar I Disorder
DJ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VNDA Stock
  4. News Vanda Pharmaceuticals Inc.